ERBB2 and breast carcinoma: The effects of gene expressions in breast cancer are well-documented, with PGR linked to a favorable prognosis, while ERBB2 and MKI67 are associated with more aggressive tumors and poorer outcomes (Harris et al., Harris et al.).